OneAscent Wealth Management LLC Sells 341 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

OneAscent Wealth Management LLC cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,412 shares of the medical equipment provider’s stock after selling 341 shares during the quarter. Intuitive Surgical comprises 0.4% of OneAscent Wealth Management LLC’s investment portfolio, making the stock its 22nd biggest holding. OneAscent Wealth Management LLC’s holdings in Intuitive Surgical were worth $825,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. BlackRock Inc. grew its stake in shares of Intuitive Surgical by 1.7% in the 1st quarter. BlackRock Inc. now owns 28,918,406 shares of the medical equipment provider’s stock worth $7,387,785,000 after buying an additional 470,624 shares during the last quarter. Alliancebernstein L.P. increased its holdings in shares of Intuitive Surgical by 8.0% during the fourth quarter. Alliancebernstein L.P. now owns 7,373,473 shares of the medical equipment provider’s stock valued at $1,956,551,000 after acquiring an additional 544,463 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 1.0% in the 1st quarter. Geode Capital Management LLC now owns 6,444,995 shares of the medical equipment provider’s stock worth $1,642,287,000 after purchasing an additional 61,659 shares during the last quarter. Morgan Stanley boosted its stake in Intuitive Surgical by 29.9% in the 4th quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock worth $1,556,706,000 after purchasing an additional 1,351,002 shares in the last quarter. Finally, Jennison Associates LLC increased its stake in Intuitive Surgical by 0.5% during the 1st quarter. Jennison Associates LLC now owns 4,456,225 shares of the medical equipment provider’s stock valued at $1,138,432,000 after purchasing an additional 21,882 shares in the last quarter. 82.91% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 2,535 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $323.26, for a total value of $819,464.10. Following the completion of the transaction, the executive vice president now directly owns 7,259 shares in the company, valued at approximately $2,346,544.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 2,535 shares of the stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $323.26, for a total transaction of $819,464.10. Following the completion of the transaction, the executive vice president now owns 7,259 shares of the company’s stock, valued at approximately $2,346,544.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 50,314 shares of Intuitive Surgical stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $326.76, for a total value of $16,440,602.64. Following the completion of the sale, the chief executive officer now directly owns 17,186 shares in the company, valued at $5,615,697.36. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 60,309 shares of company stock valued at $19,649,321. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 2.7 %

NASDAQ:ISRG traded down $8.20 during trading hours on Friday, hitting $295.54. 2,792,093 shares of the stock traded hands, compared to its average volume of 1,705,966. The stock has a 50 day moving average price of $315.28 and a 200 day moving average price of $296.65. The company has a market cap of $103.85 billion, a price-to-earnings ratio of 74.07, a price-to-earnings-growth ratio of 4.25 and a beta of 1.30. Intuitive Surgical, Inc. has a 1 year low of $180.07 and a 1 year high of $358.07.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 20th. The medical equipment provider reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. Intuitive Surgical had a net margin of 21.38% and a return on equity of 12.41%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the prior year, the firm posted $0.85 EPS. Intuitive Surgical’s quarterly revenue was up 15.4% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical, Inc. will post 4.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. Truist Financial increased their price target on shares of Intuitive Surgical from $347.00 to $400.00 in a report on Wednesday, July 19th. BTIG Research lifted their target price on Intuitive Surgical from $326.00 to $373.00 in a report on Monday, July 17th. Piper Sandler upped their price target on Intuitive Surgical from $315.00 to $385.00 and gave the company an “overweight” rating in a report on Friday, July 21st. Royal Bank of Canada reiterated an “outperform” rating and issued a $360.00 price objective on shares of Intuitive Surgical in a report on Thursday, August 17th. Finally, JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $335.00 to $365.00 and gave the company an “overweight” rating in a research note on Friday, July 21st. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $343.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.